Researchers characterize the immune landscape in cancer

Findings could pave the way for the development of new therapeutic strategies

2024-02-14

(Press-News.org) New York, NY [February 14, 2024]—Researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium of the National Institutes of Health, The University of Texas MD Anderson Cancer Center, Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and others, have unveiled a detailed understanding of immune responses in cancer, marking a significant development in the field. The findings were published in the February 14 online issue of Cell [DOI: 10.1016/j.cell.2024.01.027].

Utilizing data from more than 1,000 tumors across 10 different cancers, the study is the first to integrate DNA, RNA, and proteomics (the study of proteins), revealing the complex interplay of immune cells in tumors. The data came from the Clinical Proteomic Tumor Analysis Consortium (CPTAC), a program under the National Cancer Institute.

"We aimed to improve our understanding of the mechanisms underlying the functional impairment of immune response in tumors. By closely examining genes and proteins in the tumor tissues, we discovered various patterns in immune activation and suppression," says Pei Wang, PhD, Professor of Genetics and Genomic Sciences at Icahn Mount Sinai, and the lead-corresponding author on the paper. "Our goal in unraveling these diverse immune subtypes is to help clinicians identify patient groups more responsive to immunotherapy. Revealing the specific pathways and cellular switches for each subtype can also spark new and creative ways to develop treatments."

"Each type of immune response was linked to changes in gene functions, such as how genes are modified, the messages they send, and the proteins they produce. By providing a comprehensive molecular fingerprint of the immune response in cancer, this study is expected to facilitate the development of future immunotherapy strategies," says Francesca Petralia, PhD, Assistant Professor of Genetics and Genomic Sciences at Icahn Mount Sinai, and co-corresponding author on the paper.

A key finding was that among seven subtypes identified through advanced statistical models, five included tumors from ten different types of cancer, suggesting shared immune responses across these tumors.

“When we see common immune responses and similar patterns in the way cells behave across various cancers within the same immune group, it hints that certain treatments that boost the immune system could work well for many types of cancer," says Dr. Wang.

A novel aspect of the research stems from the deep phosphoproteomic data generated for more than 1,000 tumors. This data allows researchers to see how proteins are modified. “With phosphoproteomic profiling of more than 1,000 pan-cancer tumors, we were able to computationally discover a set of key novel drug targets,” says Avi Ma’ayan, PhD, Professor, Pharmacological Sciences, Director of the Mount Sinai Center for Bioinformatics at Icahn Mount Sinai, and a senior author of the paper. “By targeting selected kinases with small molecules or other means, we may be able to convert tumors not responding to immunotherapies into tumors with better immune-therapy response.”

As part of the research, a machine-learning tool applied to digital pathology images also demonstrated correlations between different types of immune responses and the presence of certain immune cells, enhancing understanding of the environment in and around tumors.

Next, the investigators plan to validate their findings further and leverage insights in ongoing clinical studies focused on immunotherapies. This effort aims to streamline the development of biomarker panels for treatment responses and identify enhanced treatment strategies. Collaborative efforts within CPTAC are underway, including a proteogenomic study on molecular mechanisms underlying responses to immune checkpoint treatments in melanoma patients.

The paper is titled “Pan-Cancer Proteogenomics Characterization of Tumor Immunity.”

The Clinical Proteomic Tumor Analysis Consortium (CPTAC) is supported by the National Cancer Institute of the National Institutes of Health under award numbers U24CA210955, U24CA210985, U24CA210986, U24CA210954, U24CA210967, U24CA210972, U24CA210979, U24CA210993, U01CA214114, U01CA214116, U01CA214125, U24CA271114, U24CA270823. This project has also been funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261201500003I, Task Order No. HHSN26100064. Additional funding support was provided by NIH awards U24CA224260, U24CA264250, R33CA263705, P30ES017885, T32GM136542, 1F30CA265288, F30CA271622, HHMI Gilliam Fellowship GT15758; and Associazione Italiana Ricerca sul Cancro (AIRC) under IG 2018 - ID. 21846 and AIRC 5 per Mille 2018 - ID.21073. Pacific Northwest National Laboratory is operated for the Department of Energy by Battelle Memorial Institute under Contract DE-AC05-76RL01830.

Please see Cell [DOI: 10.1016/j.cell.2024.01.027] to view details on the remaining authors and competing interests.

-####-

About the Icahn School of Medicine at Mount Sinai

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.

Ranked 13th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 44 academic departments and 36 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases.

Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System.

A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into healthcare products and services that benefit the public.

Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs.

Through the Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.

The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.

-------------------------------------------------------

* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.

END

[Attachments] See images for this press release:

Researchers characterize the immune landscape in cancer 2

Researchers characterize the immune landscape in cancer 3

ELSE PRESS RELEASES FROM THIS DATE:

Altermagnetism proves its place on the magnetic family tree

2024-02-14

There is now a new addition to the magnetic family: thanks to experiments at the Swiss Light Source SLS, researchers have proved the existence of altermagnetism. The experimental discovery of this new branch of magnetism is reported in Nature and signifies new fundamental physics, with major implications for spintronics. Magnetism is a lot more than just things that stick to the fridge. This understanding came with the discovery of antiferromagnets nearly a century ago. Since then, the family of magnetic materials has been divided into two fundamental phases: the ferromagnetic branch known for several millennia and the antiferromagnetic branch. The experimental proof of a third branch of ...

A “quantum leap” at room temperature

2024-02-14

In the realm of quantum mechanics, the ability to observe and control quantum phenomena at room temperature has long been elusive, especially on a large or “macroscopic” scale. Traditionally, such observations have been confined to environments near absolute zero, where quantum effects are easier to detect. But the requirement for extreme cold has been a major hurdle, limiting practical applications of quantum technologies. Now, a study led by Tobias J. Kippenberg and Nils Johan Engelsen at EPFL, redefines the boundaries of what’s ...

Amazon rainforest at the threshold: loss of forest worsens climate change

2024-02-14

The Amazon rainforest could approach a tipping point, which could lead to a large-scale collapse with serious implications for the global climate system. A new Nature study by an international research team including scientists from the Potsdam Institute for Climate Impact research (PIK) reveals that up to 47 percent of the Amazonian forest is threatened and identifies climatic and land-use thresholds that should not be breached to keep the Amazon resilient. “The Southeastern Amazon has already shifted from a carbon sink to a source –meaning that the current amount of human pressure is too high for the region to maintain its status as a rainforest over the long term. But ...

Researchers uncover mechanisms behind enigmatic shapes of nuclei

2024-02-14

Nearly 150 years ago, scientists discovered that specialized blood cells serve a vital role in immune system protection against infection and illness. Certain groups of these white blood cells, now known as neutrophils, feature a nucleus that is structured strikingly different than most nuclei. The majority of cells feature round- or oval-shaped nuclei that are rigid, but neutrophils differ in that their nuclei adopt multiple lobular structures akin to that of flower petal arrangements. These unique nuclear shapes permit neutrophils to travel all over the body to identify and combat invading ...

Online images may be turning back the clock on gender bias

2024-02-14

A picture is worth a thousand words, as the saying goes, and research has shown that the human brain does indeed better retain information from images than from text. These days, we are taking in more visual content than ever as we peruse picture-packed news sites and social media platforms. And much of that visual content, according to new Berkeley Haas research published in the journal Nature, is reinforcing powerful gender stereotypes. Through a series of experiments, observations, and the help of large language models, professors Douglas Guilbeault and Solène Delecourt found that female and male gender associations are more extreme among Google Images than within text ...

Smoking has long-term effects on the immune system

2024-02-14

Like other factors such as age, sex and genetics, smoking has a major impact on immune responses. This is the finding recently made by a team of scientists at the Institut Pasteur using the Milieu Intérieur cohort of 1,000 healthy volunteers, established to understand variability in immune responses. In addition to its short-term impact on immunity, smoking also has long-term consequences. For many years after they have quit the habit, smokers are left with effects on some of their bodies' defense mechanisms acquired while smoking. These findings, which for the first time reveal a long-term memory of the effects of smoking ...

Male fertility gene discovery reveals path to success for sperm

2024-02-14

Discovery of a pair of genes that work in perfect harmony to protect male fertility, could provide new insights into some unexplained cases of the most severe form of infertility, research suggests. Genetic analysis of cases of male infertility revealed that rare mutations in a gene, known as SPOCD1, disrupts the formation of healthy sperm during the earliest stages of their development. The gene was also found to work in partnership with a previously unknown gene, C19orf84, to protect the early-stage precursors to sperm, known as germ cells, from damage. The discovery of the essential role of these ...

Genome sequencing unveils mutational impacts of radiation on mammalian cells

2024-02-14

Recent release of the waste water from Japan's Fukushima nuclear disaster stirred apprehension regarding the health implications of radiation exposure. Classified as a Group 1 carcinogen, ionizing radiation has long been associated with various cancers and genetic disorders, as evidenced by survivors and descendants of atomic bombings and the Chernobyl disaster. Despite much smaller amount, we remain consistently exposed to low levels of radiation in everyday life and medical procedures. Radiation, whether in the form of high-energy particles or electromagnetic waves, is conventionally known to break our cellular DNA, leading to cancer ...

WashU awarded up to $20 million to create portable device to scan for eye diseases

2024-02-14

In the United States, more than one-fourth of adults over age 40 have an eye disease, including glaucoma, cataracts or age-related macular degeneration, or a chronic health condition that affects the eyes, such as diabetic retinopathy. These conditions are a strain on an individual’s health as well as on the health-care system, yet early diagnosis and management can help to prevent more than 90% of severe vision loss. Chao Zhou, a professor of biomedical engineering in the McKelvey School of Engineering at Washington University in St. Louis, has been working to improve optical coherence tomography (OCT) systems that can conduct high-resolution imaging of the ...

New understanding of avian eggshell attachment – implications for medical procedures and egg industry

2024-02-14

Athletes often suffer injuries to ligaments in their knees, particularly to the anterior cruciate ligament or ACL. While surgery to replace these torn ligaments is becoming increasingly common around the world it often needs to be repeated. That’s because it has proved challenging to anchor fibrous, soft and wet ligament grafting material into hard bone. Now, McGill University researchers have new information from the eggshell membrane in chicken eggs that could help change this picture thanks to the potential it offers for improvements in tissue engineering ...

LAST 30 PRESS RELEASES:

Study reveals high rates of seafood mislabeling and ambiguous market names in Calgary, Alberta, highlighting species of conservation concern

Study shows psychedelic drug psilocybin gives comparable long-term antidepressant effects to standard antidepressants, but may offer additional benefits

Study finds symptoms of depression during pregnancy linked to specific brain activity: scientists hope to develop test for “baby blues” risk

UK study shows there is less stigma against LGBTQ people than you might think, but people with mental health problems continue to experience higher levels of stigma